Abstract
The usage of PspA antigenic protein, from S. pneumoniae surface, as a carrier protein can enhance the immunization capacity of the conjugated vaccine employed in the prevention of diseases caused by this bacterium. The cloning of this protein in E. coli enables its obtainment in large quantities. However, the production of heterologous proteins leads to stress, which can cause cell differ…